Skip to main content
TYK Medicines, Inc logo

TYK Medicines, Inc — Investor Relations & Filings

Ticker · 2410 ISIN · CNE100006L34 HKEX Manufacturing
Open in API
Filings indexed 871 across all filing types
Latest filing 2023-08-01 Regulatory Filings
Country HK Hong Kong
Listing HKEX 2410

About TYK Medicines, Inc

https://www.tykmedicines.com

TYK Medicines, Inc. is a clinical-stage biopharmaceutical company specializing in the discovery, development, and commercialization of innovative small-molecule targeted therapies. The company leverages a proprietary small molecule drug design and screening platform, with a primary strategic focus on oncology, particularly treatments for lung cancer. The lead pipeline asset, TY-9591 (Edotamidine mesylate), an EGFR-targeted therapy, is currently in the Pre-NDA stage, having demonstrated promising clinical efficacy in treating lung cancer patients with brain metastasis. The pipeline also includes assets such as TY-302 and TY-2136, alongside multiple CDK inhibitors in clinical development, reflecting a commitment to addressing unmet medical needs in targeted cancer treatment.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023
Regulatory Filings Classification · 95% confidence The document is a monthly return report for an equity issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules. It details movements in issued shares, confirms compliance with listing rules, and is submitted to the Hong Kong Exchanges and Clearing Limited. The content focuses on share capital movements and confirmations related to securities issuance, typical of regulatory compliance filings rather than financial performance reports or management commentary. The document is about reporting share capital and securities movements, not about announcing a report or providing financial results. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-08-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023
Regulatory Filings Classification · 95% confidence The document is a monthly return report for movements in securities, specifically for Namyue Holdings Limited, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in issued shares, confirms compliance with listing rules, and provides information about share capital and securities issued. The document is structured as a regulatory return rather than a financial report or announcement of financial results. It does not contain financial statements or management discussion but is a compliance filing related to securities movements under exchange listing rules. This type of document fits best under Regulatory Filings (RNS) as it is a regulatory compliance submission that does not fall into other specific categories like capital changes or director dealings.
2023-07-04 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an announcement of the poll results from the Annual General Meeting (AGM) of Namyue Holdings Limited held on 16 June 2023. It details the voting outcomes on various resolutions including approval of audited financial statements, re-election of directors, appointment of auditors, and share issuance mandates. The document does not contain the full AGM materials or presentations but reports the official voting results. The document length is 3390 characters, which is relatively short and consistent with a voting results announcement rather than a full report. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2023-06-16 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2023
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' for the month ended 31 May 2023. It details movements in issued shares, confirms compliance with listing rules, and is submitted to the Hong Kong Exchanges and Clearing Limited. The content focuses on share capital movements and confirmations related to securities issuance, not on financial performance, management changes, or earnings. The document length is about 5554 characters, which is substantive but the content is regulatory in nature, reporting share capital movements and confirmations. This type of document is a regulatory filing related to share capital movements and confirmations under exchange rules, fitting best under the 'Regulatory Filings' category (RNS). It is not an announcement of a report, nor a full financial report or earnings release, nor a capital financing update. Therefore, the classification is RNS with high confidence.
2023-06-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2023
Regulatory Filings Classification · 95% confidence The document is a monthly return report for movements in securities, specifically for Namyue Holdings Limited, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in issued shares, confirms compliance with listing rules, and provides information about share capital and securities issued. The document is regulatory in nature, reporting share capital and securities movements, but it is not a full financial report, earnings release, or management discussion. It is also not an announcement of voting results, nor a proxy statement, nor a capital raising update. The document is a regulatory filing reporting share capital movements and confirmations related to securities issuance under exchange rules. Given the nature and format, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2023-05-04 English
UNAUDITED FINANCIAL INFORMATION FOR THE THREE MONTHS ENDED 31 MARCH 2023
Interim / Quarterly Report Classification · 95% confidence The document is titled 'UNAUDITED FINANCIAL INFORMATION FOR THE THREE MONTHS ENDED 31 MARCH 2023' and contains detailed financial data such as revenue, loss attributable to shareholders, total assets, and shareholders' equity for the quarter ended 31 March 2023. It includes comparative figures for the same period in the previous year and discusses operational performance and financial highlights. The document explicitly states it is unaudited and covers a three-month period, which aligns with an interim or quarterly report. The length of the document (5977 characters) and the presence of substantive financial data confirm it is a financial report rather than a brief announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q1 2023
2023-04-28 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.